US Stock MarketDetailed Quotes
BNTX BioNTech
- 119.745
- -0.185-0.15%
Trading Oct 2 11:16 ET
28.47BMarket Cap-51042P/E (TTM)
120.010High115.230Low253.66KVolume118.920Open119.930Pre Close30.05MTurnover0.29%Turnover Ratio28.25P/E (Static)237.77MShares131.49052wk High1.35P/B10.41BFloat Cap76.53052wk Low--Dividend TTM86.97MShs Float457.931Historical High--Div YieldTTM3.99%Amplitude12.361Historical Low118.464Avg Price1Lot Size
BioNTech Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.26%128.7M | -85.31%187.6M | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B | -43.14%3.46B |
| Operating revenue | -23.26%128.7M | -85.31%187.6M | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B | -43.14%3.46B |
| Cost of revenue | -63.29%59.8M | -38.44%59.1M | -79.97%599.8M | -2.40%179.1M | -78.51%161.8M | -78.69%162.9M | -92.58%96M | 2.87%3B | -68.54%183.5M | -37.86%752.8M |
| Gross profit | 1,335.42%68.9M | -89.12%128.5M | -77.51%3.22B | -68.25%1.3B | -72.92%733.5M | -99.80%4.8M | -76.75%1.18B | -10.89%14.32B | -17.27%4.09B | -44.45%2.71B |
| Operating expense | 82.20%1.04B | 20.72%635.7M | 15.07%2.32B | 10.99%701.9M | 33.72%651.6M | 11.48%568.1M | 36.67%526.6M | 76.77%2.01B | 72.88%632.4M | 53.34%487.3M |
| Selling and administrative expenses | 33.28%183.8M | 6.94%132.6M | 3.05%557.7M | 3.03%149.4M | 1.07%150.8M | -4.57%137.9M | 17.98%124M | 65.40%541.2M | 3.72%145M | 89.58%149.2M |
| -Selling and marketing expense | -28.73%12.9M | 27.87%15.6M | 5.38%62.7M | 23.29%18M | 12.50%14.4M | 1.69%18.1M | -14.69%12.2M | 18.06%59.5M | -18.44%14.6M | 21.90%12.8M |
| -General and administrative expense | 42.65%170.9M | 4.65%117M | 2.76%495M | 0.77%131.4M | 0.00%136.4M | -5.45%119.8M | 23.13%111.8M | 74.02%481.7M | 6.97%130.4M | 100.00%136.4M |
| Research and development costs | 56.56%584.6M | 51.95%507.5M | 16.01%1.78B | 13.34%577.8M | 45.67%497.9M | -6.56%373.4M | 16.86%334M | 61.93%1.54B | 87.77%509.8M | 31.26%341.8M |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | 76.09%8.1M | ---- | ---- | ---- | ---- | --4.6M |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | 76.09%8.1M | ---- | ---- | ---- | ---- | --4.6M |
| Other operating expenses | 369.54%266.7M | -106.41%-4.4M | 61.14%-25.8M | 80.67%-2.3M | 37.35%-5.2M | 250.26%56.8M | 1,325.00%68.6M | 51.99%-66.4M | 73.85%-11.9M | 61.03%-8.3M |
| Operating profit | -71.52%-966.2M | -177.51%-507.2M | -92.65%904.2M | -82.73%598M | -96.31%81.9M | -129.30%-563.3M | -86.06%654.4M | -17.57%12.3B | -24.46%3.46B | -51.27%2.22B |
| Net non-operating interest income expense | 6.15%160.4M | 229.08%175.4M | 1,081.42%349.7M | 218.80%117M | 2,561.76%90.5M | 37.74%151.1M | 959.68%53.3M | 214.73%29.6M | 310.92%36.7M | 666.67%3.4M |
| Non-operating interest income | 10.04%167.7M | 118.83%180.1M | 637.32%357.6M | 210.31%120.4M | 1,101.30%92.5M | 31.95%152.4M | 16,360.00%82.3M | 3,133.33%48.5M | 12,833.33%38.8M | 1,183.33%7.7M |
| Non-operating interest expense | 461.54%7.3M | -83.79%4.7M | ---- | ---- | -53.49%2M | -77.59%1.3M | --29M | ---- | ---- | 437.50%4.3M |
| Total other finance cost | ---- | ---- | -58.20%7.9M | ---- | ---- | ---- | ---- | -30.77%18.9M | ---- | ---- |
| Other net income (expense) | -110.92%-67.8M | 84.13%-51.8M | -74.95%55M | 327.77%620.7M | -320.91%-326.5M | 99.82%219.6M | ||||
| Gain on sale of security | ---- | ---- | -106.16%-38.4M | 93.08%-22.4M | -74.95%55M | ---- | ---- | 304.74%623.7M | -306.31%-323.5M | 99.82%219.6M |
| Special income (charges) | ---- | ---- | -880.00%-29.4M | ---- | ---- | ---- | ---- | 66.67%-3M | ---- | ---- |
| -Less:Other special charges | ---- | ---- | 880.00%29.4M | ---- | ---- | ---- | ---- | -66.67%3M | ---- | ---- |
| Income before tax | -95.49%-805.8M | -146.88%-331.8M | -90.84%1.19B | -79.10%663.2M | -90.70%227.4M | -117.77%-412.2M | -85.90%707.7M | -13.91%12.95B | -32.70%3.17B | -47.63%2.44B |
| Income tax | 100.90%2M | -108.13%-16.7M | -92.73%255.8M | -77.03%205.3M | -89.87%66.8M | -134.27%-221.8M | -84.42%205.5M | -25.96%3.52B | -42.24%893.9M | -54.74%659.2M |
| Net income | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B |
| Net income continuous Operations | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B |
| Basic earnings per share | -325.32%-3.36 | -163.29%-1.31 | -90.02%3.87 | -79.64%1.91 | -90.98%0.67 | -111.52%-0.79 | -86.32%2.07 | -8.06%38.78 | -27.62%9.38 | -43.46%7.43 |
| Diluted earnings per share | -325.32%-3.36 | -163.90%-1.31 | -89.86%3.83 | -79.59%1.89 | -90.40%0.67 | -112.25%-0.79 | -85.60%2.05 | -4.69%37.77 | -23.91%9.26 | -43.48%6.98 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
